SY

Synergy Innovation Co., Ltd.

Researches, develops, and invests in drugs, medical devices, and health foods.

048870 | KO

Overview

Corporate Details

ISIN(s):
KR7048870000
LEI:
Country:
South Korea
Address:
경기도 성남시 중원구 사기막골로 52 5층(상대원동, 선텍시티2), 성남시

Description

Synergy Innovation Co., Ltd. is a company focused on the biotechnology sector, which it considers a primary growth engine. The company engages in research, development, and investment activities related to new and generic drugs, medical devices, and health functional foods. Its R&D efforts encompass areas such as genetics and the development of cell culture mediums. Synergy Innovation actively pursues growth through a combination of internal projects and strategic external investments to expand its portfolio.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-09-30 00:00
주식등의대량보유상황보고서(일반)
Korean 103.1 KB
2022-09-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.3 KB
2022-08-23 00:00
주식등의대량보유상황보고서(일반)
Korean 100.5 KB
2022-08-12 00:00
반기보고서 (2022.06)
Korean 1.1 MB
2022-08-05 00:00
주식등의대량보유상황보고서(일반)
Korean 100.7 KB
2022-08-05 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.5 KB
2022-07-13 00:00
주식등의대량보유상황보고서(일반)
Korean 101.4 KB
2022-06-30 00:00
주식등의대량보유상황보고서(일반)
Korean 102.9 KB
2022-06-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.6 KB
2022-06-15 00:00
[기재정정]투자판단관련주요경영사항(자회사 지분 매각을 위한 Binding MOU(양해각서) 체결)
Korean 14.5 KB
2022-06-15 00:00
주요사항보고서(타법인주식및출자증권양도결정)
Korean 17.7 KB
2022-06-10 00:00
[기재정정]투자판단관련주요경영사항(자회사 지분 매각을 위한 Binding MOU(양해각서) 체결)
Korean 14.5 KB
2022-05-20 00:00
주식등의대량보유상황보고서(일반)
Korean 95.5 KB
2022-05-13 00:00
분기보고서 (2022.03)
Korean 1.3 MB
2022-05-11 00:00
주식등의대량보유상황보고서(일반)
Korean 91.9 KB

Automate Your Workflow. Get a real-time feed of all Synergy Innovation Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Synergy Innovation Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Synergy Innovation Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.